74 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34854174 | Tacrolimus-induced acute pancreatitis and diabetic ketoacidosis (DKA) in pediatric kidney transplant recipient. | 2022 Mar | 1 |
2 | 35212883 | Relation of adipose tissue and skeletal muscle FKBP5 expression with insulin sensitivity and the regulation of FKBP5 by insulin and free fatty acids. | 2022 Jun | 1 |
3 | 35294797 | Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus-induced diabetes mellitus and nephrotoxicity in a rat model. | 2022 Jun | 2 |
4 | 31941840 | Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable. | 2020 Jan 16 | 2 |
5 | 32894758 | Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion From Human Islets. | 2020 Nov 1 | 3 |
6 | 33202516 | Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study. | 2020 Dec | 2 |
7 | 31402251 | Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus. | 2019 Sep | 1 |
8 | 31490380 | Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus: A case report with review of literature. | 2019 Sep | 2 |
9 | 29380240 | Calcineurin is an important factor involved in glucose uptake in human adipocytes. | 2018 Aug | 1 |
10 | 27458792 | Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver Transplantation. | 2017 Jan | 1 |
11 | 28720321 | No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure. | 2017 Sep | 1 |
12 | 26735686 | Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. | 2016 | 1 |
13 | 26849622 | Insulin Increases Expression of TRPC6 Channels in Podocytes by a Calcineurin-Dependent Pathway. | 2016 | 3 |
14 | 25431882 | The Effect of Tacrolimus on Reactive Oxygen Species and Total Antioxidant Status in Pancreatic Beta Cell Line. | 2015 Dec | 2 |
15 | 25644968 | Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients. | 2015 May | 2 |
16 | 24507957 | Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment. | 2014 Apr | 1 |
17 | 25255841 | Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. | 2014 Nov | 3 |
18 | 23160140 | The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. | 2013 Jan 30 | 2 |
19 | 24085506 | Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. | 2013 Nov | 1 |
20 | 21988494 | Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers. | 2012 Apr | 1 |
21 | 22310596 | Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. | 2012 Jan | 1 |
22 | 22814600 | Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. | 2012 Jul 17 | 1 |
23 | 22897149 | Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation. | 2012 Oct | 1 |
24 | 23003106 | The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients. | 2012 Dec | 1 |
25 | 23018257 | Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation. | 2012 Jul-Sep | 1 |
26 | 21471328 | No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus. | 2011 Nov | 1 |
27 | 21720672 | Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. | 2011 Spring | 2 |
28 | 20145524 | Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. | 2010 Feb 15 | 2 |
29 | 20199368 | Family history of diabetes as a new determinant of insulin sensitivity and secretion in patients who have undergone a simultaneous pancreas-kidney transplant. | 2010 Mar | 1 |
30 | 19134532 | Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. | 2009 Jan | 1 |
31 | 19161445 | Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. | 2009 Apr | 1 |
32 | 19500470 | Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. | 2009 | 2 |
33 | 19543067 | Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. | 2009 Jun 27 | 1 |
34 | 19628039 | Tacrolimus causes a blockage of protein secretion which reinforces its immunosuppressive activity and also explains some of its toxic side-effects. | 2009 Dec | 2 |
35 | 18431361 | Regulated insulin delivery from human epidermal cells reverses hyperglycemia. | 2008 Jun | 1 |
36 | 18703143 | Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation. | 2008 Nov | 5 |
37 | 16549165 | The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation. | 2006 Mar | 1 |
38 | 16569741 | Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. | 2006 Jun | 1 |
39 | 16680182 | Immunosuppression for islet transplantation. | 2006 Apr | 2 |
40 | 15479952 | Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. | 2005 Feb | 5 |
41 | 15677500 | Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. | 2005 Feb | 1 |
42 | 15919458 | Safety analysis after tacrolimus immunosuppression in renal transplant recipients in Japan: 5-year results in >1500 patients. | 2005 May | 1 |
43 | 15932724 | [Study of the effects of immunosuppressive agents on human islet cells in vitro]. | 2005 Mar 16 | 2 |
44 | 16235347 | Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. | 2005 Oct 19 | 1 |
45 | 16298573 | Audit of diabetes in a renal transplant population. | 2005 Oct | 1 |
46 | 15041369 | Immunosuppression for pancreatic islet transplantation. | 2004 Mar | 2 |
47 | 15575024 | Evaluating mechanisms of post-transplant diabetes mellitus. | 2004 Dec | 5 |
48 | 12644894 | Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. | 2003 Mar | 7 |
49 | 12761338 | Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. | 2003 Jun | 5 |
50 | 12808614 | Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. | 2003 Jun | 1 |